Home / Companies / Cellex-C International

Cellex-C International FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

Latest inspection OAI · Jan 19, 2017
Last warning letter 2017

Inspections 2

1 OAI

Recalls 0 0 Class I

Warning letters 1 Latest Aug 2, 2017

510(k) clearances 0 None on file

Cellex-C International has 0 FDA recalls, 2 inspections, 0 510(k) clearances and 1 compliance action on record. FDA has issued 1 warning letter to Cellex-C International, the most recent on Aug 2, 2017.

What these totals cover: FDA records filed under the name "Cellex-C International".

Latest inspection: Jan 19, 2017 · OAI

Summary

Record counts and when each FDA source was last refreshed
Records	Count	Last refreshed	Source as of	Status
Recalls	0	Nov 11, 2026 (checked Nov 15, 2026, unchanged)	File dated Nov 10, 2026	Current
510(k) clearances	0	Nov 15, 2026	File dated Nov 9, 2026	Current
Inspections	2	Nov 15, 2026	Newest record Nov 5, 2026	Current
Compliance actions	1	Nov 2, 2026	Newest record Oct 29, 2026	Current

Reviewing Cellex-C International as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Cellex-C International yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Cellex-C International FDA Warning Letters

1 warning letter on Aug 2, 2017.

Issued	Subject	Issuing office	Close-out letter
Aug 2, 2017 · Record page

A warning letter is FDA's formal notice that a company has violated FDA requirements. Each date links to the letter on fda.gov where FDA has it online. Search the text of every letter with the FDA warning letter search.

Recent FDA inspections

2 inspections from Jan 17, 2012 to Jan 19, 2017.

Date	Site	Product	Classification	FEI
Jan 19, 2017	Toronto, Canada	Drugs	Official Action Indicated (OAI)	3003525539
Jan 17, 2012	Toronto, Canada	Drugs	Voluntary Action Indicated (VAI)	3002409942

NAI: No objectionable conditions or practices were found during the inspection.
VAI: Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI: Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

Compliance Actions

FDA's compliance actions data lists 1 compliance action under Cellex-C International: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.

Most recent: Warning Letter, Aug 2, 2017.

The warning letters in this data are listed above, together with the letters FDA posts online; a letter found in both is shown once. Other actions are not listed on this page. Search them with the FDA warning letter search or browse all compliance actions.

FDA-inspected facilities

2 inspected sites, newest inspection first.

Facility	Location	Inspections	Latest
FEI 3003525539	Toronto, Canada	1	Jan 19, 2017
FEI 3002409942	Toronto, Canada	1	Jan 17, 2012

Cellex-C International and the FDA: common questions

Has Cellex-C International received an FDA warning letter?

Yes. FDA has issued 1 warning letter to Cellex-C International. The most recent is dated Aug 2, 2017.

Has Cellex-C International received an FDA Form 483?

FDA has not published a Form 483 for "Cellex-C International" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Cellex-C International?

The most recent FDA inspection on file ended Jan 19, 2017 at Toronto, Canada and was classified OAI. FDA has 2 inspections of Cellex-C International on file, 1 of them classified OAI (official action indicated).

Need more than this page shows? Ask about Cellex-C International in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.